EUVIMEDEUVIMED entdecken
Open Access

Free fatty acid receptor 4 in cardiac myocytes ameliorates ischaemic cardiomyopathy

Michael J Zhang, Sara J Puccini, Sergey Karachenets, Dylan J Gyberg, Shanmugasundaram Pakkiriswami, Megan K Sumera, Ryan Gemilere, Natalie L Weir, Sebastian L Torres, Chastity L Healy, Brian A Harsch, Steven C Wu und 3 weitere

Cardiovascular Research · 06.11.2026 · 122 (15) · 2141-2159

DOI: 10.1093/cvr/cvag175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 17.08.2026. Verfasst von Michael J Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biology and Physiology, University of Minnesota Medical School, 3-141 CCRB, 2231 6th Street SE, Minneapolis, MN 55414, USA. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Myocardial Reperfusion Injury, Receptors, G-Protein-Coupled, Myocardial Infarction. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Heart Lung Blood Institute, NIDDK NIH HHS, American Heart Association Postdoctoral Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Free fatty acid receptor 4 (Ffar4) is a receptor for long-chain fatty acids that attenuates heart failure driven by increased afterload. Recent findings suggest that Ffar4 prevents ischaemic injury in brain, liver, and kidney, and therefore, we hypothesized that Ffar4 would attenuate cardiac ischaemic injury. Methods and results Using a mouse model of ischaemia-reperfusion (I/R), we found in mice with systemic deletion of Ffar4 (Ffar4KO), loss of Ffar4 impaired the recovery of left ventricular systolic function post-I/R with no effect on initial infarct size. To identify potential mechanistic explanations for the cardioprotective effects of Ffar4, we performed bulk RNAseq to compare the transcriptomes from wild-type (WT) and Ffar4KO infarcted myocardium 3-days post-I/R. The transcriptome analysis identified the downregulation of several metabolic pathways suggesting impaired mitochondrial function in the infarcted Ffar4KO myocardium. Mechanistically, basal mitochondrial function and morphology were impaired in cardiac myocytes from Ffar4KO mice corroborating the results of the transcriptome analysis. Interestingly, phosphodiesterase 6c (Pde6c), which degrades cGMP, was the most upregulated gene in the Ffar4KO heart. Further, the soluble guanylyl cyclase stimulator, vericiguat, failed to increase cGMP in Ffar4KO cardiac myocytes, suggesting increased phosphodiesterase activity. Finally, cardiac myocyte-specific overexpression of Ffar4 in vivo and activation of Ffar4 in cardiac myocytes in vitro attenuated ischaemic/hypoxic injury respectively.

Conclusion

Our results define a novel protective role for Ffar4 in cardiac myocytes to attenuate systolic dysfunction and prevent ischaemic cardiomyopathy post I/R by preserving mitochondrial function and activating cGMP signalling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacMyocardial Reperfusion InjuryReceptors, G-Protein-CoupledMyocardial InfarctionCardiomyopathiesAnimalsMice, KnockoutDisease Models, AnimalMitochondria, HeartSignal TransductionVentricular Function, LeftMice, Inbred C57BLMaleTranscriptomeEnergy MetabolismRecovery of FunctionCyclic GMP

Stichwörter der Autor:innen

Cardiac myocyteFree fatty acid recept or 4 (Ffar4)Ischaemic cardiomyopathyMitochondriaOxidative stress

Substanzen

Receptors, G-Protein-CoupledFFAR4 protein, mouseCyclic GMP

Autor:innen und Institutionen

  • Department of Integrative Biology and Physiology, University of Minnesota Medical School, 3-141 CCRB, 2231 6th Street SE, Minneapolis, MN 55414, USA.
  • Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Lillehei Heart Institute, University of Minnesota Medical School, 4-156 CCRB, 2231 6th Street SE, Minneapolis, MN 55455, USA.
  • Department of Nutritional Sciences, Pennsylvania State University, 110 Chandlee Laboratory, University Park, PA 16802, USA.

ORCID-Profile: Timothy D O'Connell

Förderung

  • National Heart Lung Blood Institute
  • NIDDK NIH HHS
  • American Heart Association Postdoctoral Fellowship
  • NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Zhang, M. J., Puccini, S. J., Karachenets, S., Gyberg, D. J., Pakkiriswami, S., Sumera, M. K., Gemilere, R., Weir, N. L., Torres, S. L., Healy, C. L., Harsch, B. A., Wu, S. C., Liu, J. C., Shearer, G. C., & O'Connell, T. D. (2026). Free fatty acid receptor 4 in cardiac myocytes ameliorates ischaemic cardiomyopathy. Cardiovascular Research, 122(15), 2141-2159. https://doi.org/10.1093/cvr/cvag175

Vancouver

Zhang MJ, Puccini SJ, Karachenets S, Gyberg DJ, Pakkiriswami S, Sumera MK, et al. Free fatty acid receptor 4 in cardiac myocytes ameliorates ischaemic cardiomyopathy. Cardiovascular Research. 2026;122(15):2141-2159. doi:10.1093/cvr/cvag175

BibTeX
@article{Zhang2026,
  author = {Zhang, Michael J and Puccini, Sara J and Karachenets, Sergey and Gyberg, Dylan J and Pakkiriswami, Shanmugasundaram and Sumera, Megan K and Gemilere, Ryan and Weir, Natalie L and Torres, Sebastian L and Healy, Chastity L and Harsch, Brian A and Wu, Steven C and Liu, Julia C and Shearer, Gregory C and O'Connell, Timothy D},
  title = {Free fatty acid receptor 4 in cardiac myocytes ameliorates ischaemic cardiomyopathy},
  journal = {Cardiovascular Research},
  year = {2026},
  volume = {122},
  number = {15},
  pages = {2141--2159},
  doi = {10.1093/cvr/cvag175}
}
Kostenlos starten →